CHIR-265 is a potent selective inhibitor of c-Raf/B-Raf/mutB-Raf that effectively inhibits proliferation and survival of cancer cell lines with Ras/Raf pathway mutations

被引：0

|

作者：

Amiri, Payman ^{[1
]}

Aikawa, Mina E. ^{[1
]}

Dove, Jeff ^{[1
]}

Stuart, Darrin D. ^{[1
]}

Poon, Daniel ^{[1
]}

Pick, Teresa ^{[1
]}

Ramurthy, Savithri ^{[1
]}

Subramanian, Sharadha ^{[1
]}

Levine, Barry ^{[1
]}

Costales, Abran ^{[1
]}

Harris, Alex ^{[1
]}

Paul, Renhow ^{[1
]}

机构：

[1] Chiron Corp, Emeryville, CA 94608 USA

来源：

CANCER RESEARCH | 2006年 / 66卷 / 08期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

4855

引用

收藏

页数：2

相关论文

共 24 条

[21] 20(S)-Ginsenoside Rg3 Inhibits Lung Cancer Cell Proliferation by Targeting EGFR-Mediated Ras/Raf/MEK/ERK Pathway
Liang, Yuan
Zhang, Tiehua
Jing, Siyuan
Zuo, Peng
Li, Tiezhu
Wang, Yongjun
Xing, Shaochen
Zhang, Jie
Wei, Zhengyi
AMERICAN JOURNAL OF CHINESE MEDICINE, 2021, 49 (03): : 753 - 765
[22] A selective Raf kinase inhibitor induces cell death and tumor regression of human cancer cell lines encoding B-RafV600E mutation
Laquerre, Sylvie
Amone, Marc
Moss, Katherine
Yang, Jingsong
Fisher, Kelly
Kane-Carson, Laurie S.
Smitheman, Kimberly
Ward, Jessica
Heidrich, Bradley
Rheault, Tara
Adjabeng, George
Hornberger, Keith
Stellwagen, John
Waterson, Alex
Han, Chao
Mook, Robert A., Jr.
Uehling, David
King, Alastair J.
MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
[23] Identification of molecular determinants of response to GSK1120212B, a potent and selective MEK inhibitor, as a single agent and in combination in RAS/RAF mutant non-small cell lung carcinoma cells
Liu, Li
Hong, Shi
Zhang, Vivian
Gilmer, Tona
CANCER RESEARCH, 2011, 71
[24] Phytochemicals from Allium tuberosum Rottler ex Spreng Show Potent Inhibitory Activity against B-Raf, EGFR, K-Ras, and PI3K of Non-Small Cell Lung Cancer Targets
Nath, Rajat
Singha, Shreeta
Nath, Deepa
Das, Gitishree
Patra, Jayanta Kumar
Das Talukdar, Anupam
APPLIED SCIENCES-BASEL, 2022, 12 (22):